Emerging Technologies for Hemodialysis Access Management: Are They Worth It?

[1]  M. Venermo,et al.  Drug-Coated Versus Plain Balloon Angioplasty In Arteriovenous Fistulas: A Randomized, Controlled Study With 1-Year Follow-Up (The Drecorest Ii-Study) , 2018, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[2]  S. Trerotola,et al.  Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[3]  Amy C. Dwyer,et al.  Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. , 2016, Journal of vascular surgery.

[4]  Z. Haskal,et al.  Prospective, Randomized, Concurrently-Controlled Study of a Stent Graft versus Balloon Angioplasty for Treatment of Arteriovenous Access Graft Stenosis: 2-Year Results of the RENOVA Study. , 2016, Journal of vascular and interventional radiology : JVIR.

[5]  D. Scheinert,et al.  Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. , 2015, The New England journal of medicine.

[6]  S. Spiliopoulos,et al.  Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. , 2015, Journal of vascular and interventional radiology : JVIR.

[7]  S. Trerotola,et al.  Stent graft versus balloon angioplasty for failing dialysis-access grafts. , 2010, The New England journal of medicine.

[8]  R. Novelline.  Percutaneous transluminal angioplasty: newer applications. , 1980, AJR. American journal of roentgenology.